Evaluation of the Effects of Ozone Therapy on Covid 19 Positive Patients

Official Title

Ozone Therapy on Covid 19 Positive Patients

Brief Summary

Evaluation of the effects of ozone therapy given in addition to the treatment they received in covid 19 positive patients (hydroxychloroquine + azithromycin)

Status

Active, not recruiting

Conditions

COVID19

Ozene

Interventions

Other: ozone therapy group (covid positive)
The effects of ozone therapy given in addition to the treatment they received in covid 19 positive patients (hydroxychloroquine + azithromycin)

Eligibility Criteria

Inclusion Criteria:

- covid 19 positive

- no lung disease

- 18- 45 years old women

Exclusion Criteria:

- covid 19 negative

- lung diease

- additional disease

- men

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years~Maximum: 45 Years

Countries

Turkey

NCT Number

NCT04337866

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Kanuni Sultan Suleyman Training and Research Hospital

Evaluation of the Effects of Ozone Therapy on Covid 19 Positive Patients

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA